NAPc2

NAPc2 · ARCA Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NAPc2, covering 2008-05-07 to 2008-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer [Phase 1, Phase 2]

See pricing